Search research articles
Contact Us
Filters
Showing results (271-280 of 706) with videos related to
Page
of 71
Sort By:
The American Journal of Cardiology
|
May 29, 2007
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative
Sumit Tickoo, Matthew T Roe, Eric D Peterson, et al.
Journal of the American Heart Association
|
November 7, 2012
Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program
Nathan M Boyer, Warren K Laskey, Margueritte Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 25, 2016
Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial
Grant W Reed, Christopher P Cannon, Jill Waalen, et al.
American Heart Journal
|
April 30, 2017
Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program
Prakash Deedwania, Tushar Acharya, Kamal Kotak, et al.
Circulation
|
May 23, 2012
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes
Benjamin A Steinberg, Xin Zhao, Paul A Heidenreich, et al.
Journal of Thrombosis and Thrombolysis
|
September 30, 2006
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial
Benjamin M Scirica, Christopher P Cannon, Richard Cooper, et al.
International Journal of Cardiology
|
June 16, 2018
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
Tracey G Simon, Kathleen E Corey, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
March 5, 2009
Individual quality improvement in acute coronary syndromes: a performance improvement initiative
Christopher P Cannon, James W Hoekstra, David M Larson, et al.
The American Journal of Cardiology
|
January 6, 2009
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation
William R Lewis, Gregg C Fonarow, Kenneth A LaBresh, et al.
Clinical Cardiology
|
February 5, 2013
Prognostic evaluation of catalytic iron in patients with acute coronary syndromes
Dylan L Steen, Christopher P Cannon, Suhas S Lele, et al.
Page
of 71
Search research articles
Search
Showing results (271-280 of 706) with videos related to
Sort By:
Page
of 71
The American Journal of Cardiology
|
May 29, 2007
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative
Sumit Tickoo, Matthew T Roe, Eric D Peterson, et al.
Journal of the American Heart Association
|
November 7, 2012
Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program
Nathan M Boyer, Warren K Laskey, Margueritte Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 25, 2016
Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial
Grant W Reed, Christopher P Cannon, Jill Waalen, et al.
American Heart Journal
|
April 30, 2017
Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program
Prakash Deedwania, Tushar Acharya, Kamal Kotak, et al.
Circulation
|
May 23, 2012
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes
Benjamin A Steinberg, Xin Zhao, Paul A Heidenreich, et al.
Journal of Thrombosis and Thrombolysis
|
September 30, 2006
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial
Benjamin M Scirica, Christopher P Cannon, Richard Cooper, et al.
International Journal of Cardiology
|
June 16, 2018
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
Tracey G Simon, Kathleen E Corey, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
March 5, 2009
Individual quality improvement in acute coronary syndromes: a performance improvement initiative
Christopher P Cannon, James W Hoekstra, David M Larson, et al.
The American Journal of Cardiology
|
January 6, 2009
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation
William R Lewis, Gregg C Fonarow, Kenneth A LaBresh, et al.
Clinical Cardiology
|
February 5, 2013
Prognostic evaluation of catalytic iron in patients with acute coronary syndromes
Dylan L Steen, Christopher P Cannon, Suhas S Lele, et al.
Page
of 71